For the Inventor, By the Inventor

Enter inventor name

San Diego, CA, United States of America

Mary Erickson

USPTO Granted Patents = 21 (Patent Applications = 9)

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 7 (Patent Applications = 12)

Average Co-Inventor Count = 4.7

ph-index = 6

Forward Citations = 141(Granted Patents)

Company Filing History:

Amylin Pharmaceuticals, Inc.

Serono Genetics Institute S.a.

Astrazeneca Pharmaceuticals LP

Aegerion Pharmaceuticals, Inc.

Amryt Pharmaceuticals Inc.

where one patent can have more than one assignee

Years Active: 2003-2022

Loading Chart...

Loading Chart...

Loading Chart...

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11535659 - Engineered polypeptides having enhanced duration of action (2022-12-27),

2. 10087228 - Chimeric leptin polypeptide and method of using the same (2018-10-02),

3. 9879063 - Engineered polypeptides having enhanced duration of action and reduced immunogenicity (2018-01-30),

4. 9593154 - Engineered polypeptides having enhanced duration of action (2017-03-14),

5. 9382304 - Engineered polypeptides having enhanced duration of action with reduced immunogenicity (2016-07-05),

6. 9133260 - GIP analog and hybrid polypeptides with selectable properties (2015-09-15),

7. 8895498 - GIP and exendin hybrid polypeptides (2014-11-25),

8. 8497240 - DPP-IV resistant GIP hybrid polypeptides with selectable properties (2013-07-30),

9. 8404637 - GIP analog and hybrid polypeptides with selectable properties (2013-03-26),

10. 8263545 - GIP analog and hybrid polypeptides with selectable properties (2012-09-11),

11. 7928060 - Amylin family polypeptide-6 (AFP-6) analogs and methods of making and using them (2011-04-19),

12. 7671024 - OBG3 globular head and uses thereof (2010-03-02),

13. 7470669 - Isolated polypeptide comprising a leptin fragment (2008-12-30),

14. 7393661 - Nucleic acids encoding OBG3 polypeptides (2008-07-01),

15. 7348406 - Metabolic gene polynucleotides and polypeptides and uses thereof (2008-03-25),

Title: The Innovative Journey of Mary Erickson

Introduction: Mary Erickson, a pioneering inventor based in San Diego, CA, has made significant contributions to the field of technology with her groundbreaking inventions and patents.

Latest Patents: Mary Erickson's latest patents include a cutting-edge wearable device that revolutionizes the healthcare industry by monitoring vital signs in real-time and a solar-powered irrigation system designed to enhance sustainability in agriculture.

Career Highlights: With a career spanning over two decades, Mary Erickson has established herself as a leading figure in the innovation landscape. Her inventions have not only improved the quality of life for many but have also garnered international recognition for their ingenuity.

Collaborations: Throughout her career, Mary Erickson has collaborated with top research institutions, universities, and tech companies to further develop and commercialize her inventions. Her collaborative spirit has led to the successful implementation of cutting-edge technologies in various sectors.

Conclusion: Mary Erickson's passion for innovation, coupled with her relentless drive to push the boundaries of technology, has solidified her position as a trailblazing inventor. Her dedication to creating solutions that address real-world challenges continues to inspire the next generation of inventors worldwide.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…